Chauncey:
Who would I report to? <a href=" http://www.creativesummit.org/olanzapine-renal-dosing ">olanzapine dosing</a> Pfizer said tofacitinib, already approved to treat rheumatoid arthritis under the brand name Xeljanz, showed similar dose-response trends and similar safety trends as those seen in an earlier mid-stage trial of tofacitinib for treatment of psoriasis.
    Chauncey写于2016/3/16 1:29:26